FDA Gives Emergency Authorization to Pfizer Covid Pill

All, News
The U.S. Food and Drug Administration authorized the emergency use of an antiviral COVID-19 pill, the pill’s maker Pfizer Inc. said Wednesday. The company says the pill, which is to be taken with another antiviral drug, ritonavir, is 90% effective in preventing hospitalization and death in high-risk people. “The…


Australian Research Identifies Kidney-Protecting Gene

All, News
Researchers in Australia have identified a gene that indicates the kidney has its own way of resisting damage. However, they have also identified a mutation of the gene that can in patients with, for example, diabetes, trigger the development of renal disease.  A gene called VANGL1 has…


Omicron Variant Spurs New Lockdown in Netherlands

All, News
“The Netherlands is shutting down again,” Prime Minister Mark Rutte said Saturday in a televised address. The new measures, beginning Sunday, Rutte said, are because of a “fifth wave” of COVID-19, due to the highly contagious omicron variant. Under the new rules, all non-essential shops…


US Workplace Vaccine Mandate Penalties to Start Jan. 10

All, News
The Occupational Health and Safety Administration said Saturday that it would not issue citations tied to its coronavirus vaccination mandate before Jan. 10, so that companies have time to adjust to and implement the requirements. The federal agency separately said there would be no citations…


Egypt Announces its First Cases of Omicron Variant

All, News
Egyptian health authorities said they have identified the country’s first cases of the highly transmissible omicron variant of the coronavirus. Three people were found to have the variant among 26 travelers who tested positive for coronavirus at Cairo International Airport, the Health Ministry said in…


Pandemic Could Extend To 2024, Pfizer Says

All, News
Pfizer Inc on Friday forecast that the COVID-19 pandemic would not be behind us until 2024 and said a lower-dose version of its vaccine for 2- to 4-year-olds generated a weaker immune response than expected, potentially delaying authorization. Pfizer Chief Scientific Officer Mikael Dolsten said…